COVID-19 vaccine tested at Emory is safe, generates immune response, early results show
An investigational vaccine designed to protect against COVID-19 was generally well tolerated and resulted in production of both binding and neutralizing antibodies in healthy adult volunteers, according to early results of an ongoing phase 1 trial.
RSSRecent News Releases »
Faculty Opinion »
What Obama knew about John Lewis
CEOs of Delta and Emory Healthcare: Everyone should wear a mask in public
In banning LGBTQ discrimination, did Supreme Court license sex discrimination?
The damage Trump has done this week extends far beyond America’s borders
We can't lose sight of the pandemic's hidden crisis: Domestic abuse, says AMA President
Featured Expert »
Andra Gillespie, Politics
Political scientist Andra Gillespie specializes in political mobilization and race and is the author of "The New Black Politician: Cory Booker, Newark and Post-Racial America."
Video »
How customized antibiotic combinations could defeat 'superbugs'
A sneaky form of antibiotic resistance called "heteroresistance" is more widespread than previously appreciated. But tracking heteroresistance might guide the choice of antibiotic combinations that can defeat bacteria regarded as invincible.
Emory in the News »
Shirley Chisholm blazed the way for every Black woman Biden is considering for VP
Washington Post, Aug. 1
ESPN: MLB commissioner warns of league shutdown if virus management doesn’t improve
MSNBC, July 31
COVID-19: What are the 4 phases of vaccine clinical trials?
USA Today, July 31
Hydroxychloroquine for COVID-19: Scientists say it's time to stop promoting the drug
NBC News, July 30
- Emory President Claire E. Sterk on the opioid crisis
